Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Terrance Mayes and Loretta Erhunmwunsee are the new leaders of the National Comprehensive Cancer Network (NCCN) Forum on Equity.
Only half the time, according to an NCCN study of people with neuroendocrine tumors. Here’s how their treatment goals differ.
Black patients with ovarian cancer were less likely than their white counterparts to be treated according to NCCN guidelines.
Plus, the vaccines “offer strong protection from severe COVID-19 for all variants” for cancer patients treated with immunotherapy.
NCCN’s new recommendations for COVID-19 vaccines include children with cancer as well as their caregivers.
The NCCN updated its guidelines for genetic testing for colorectal cancer patients; increased testing can reduce health disparities.
The levels of prostate-specific antigen in the blood can indicate further testing is needed to screen for cancer.
“I am living proof that early detection can save lives,” Tigerlily CEO Maimah Karmo said at the NCCN cancer policy summit.
A new tool helps oncologists predict which meds might lead to dangerous interactions and adverse effects in their older cancer patients.
Study: Most online pharmacies selling the chronic myeloid leukemia therapy imatinib are uncertified and could be operating unsafely.
Breast cancer experts recommend annual mammograms for all average-risk women over 40, plus screenings versus diagnostic tests and more.
The ELEVATE program enables access to high-quality smoking cessation care while minimizing costs and burden, finds a new study.
Rates of breast cancer survivors receiving annual mammograms dropped 1.5% per year from 2009 to 2016—and that’s before COVID-19 shutdowns.
A Canadian study finds an immediate cancer diagnosis decrease of 34% in March 2020, followed by a slow and incomplete recovery.
Groups sign letter detailing urgent need to regain lost ground on prevention and early detection and to accelerate cancer research.
The largest peer-reviewed study of the Pfizer-BioNTech COVID vaccine in cancer patients finds no more, and no different, side effects.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.